KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palvella Therapeutics (PVLA) Depreciation and Depletion (2016 - 2020)

Palvella Therapeutics has reported Depreciation and Depletion over the past 7 years, most recently at $530000.0 for Q2 2020.

  • Quarterly Depreciation and Depletion rose 1161.9% to $530000.0 in Q2 2020 from the year-ago period, while the trailing twelve-month figure was $1.3 million through Jun 2020, up 136.59% year-over-year, with the annual reading at $1.8 million for FY2023, 21.74% down from the prior year.
  • Depreciation and Depletion was $530000.0 for Q2 2020 at Palvella Therapeutics, up from $339000.0 in the prior quarter.
  • Over five years, Depreciation and Depletion peaked at $530000.0 in Q2 2020 and troughed at -$11764.0 in Q2 2016.
  • The 5-year median for Depreciation and Depletion is $132000.0 (2018), against an average of $157666.7.
  • Year-over-year, Depreciation and Depletion plummeted 115.39% in 2016 and then soared 1161.9% in 2020.
  • A 5-year view of Depreciation and Depletion shows it stood at $224613.0 in 2016, then tumbled by 55.03% to $101000.0 in 2017, then skyrocketed by 93.07% to $195000.0 in 2018, then rose by 19.49% to $233000.0 in 2019, then surged by 127.47% to $530000.0 in 2020.
  • Per Business Quant, the three most recent readings for PVLA's Depreciation and Depletion are $530000.0 (Q2 2020), $339000.0 (Q1 2020), and $233000.0 (Q4 2019).